Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter
NCT04856488Phase 3Recruiting
- Start
- Nov 2021
- Primary completion
- Aug 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Lugol's solution in hyperthyroidism. Started Nov 2021; status: recruiting.
02
Drugs
Lugol's solution
03
Conditions
hyperthyroidism
Beyond the preview
Go deeper on NCT04856488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04856488.